1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > Noninvasive Glucose Monitors

Noninvasive Glucose Monitors

  • March 2016
  • -
  • Greystone Research Associates

Summary

For diabetes patients, glucose monitoring is a way of life, a several-times-per-day routine critical to physiological health. But while the traditional finger prick method has been a standard disease management tool for decades, issues of patient compliance and the limitations of current methods in detecting short-term fluctuations in glucose levels have brought a host of companies into the hunt for less invasive and more user-friendly alternatives. Now the convergence of small-scale electronics and sophisticated biocompatible product designs is giving hope for a better future to millions of diabetes patients worldwide. Noninvasive glucose monitors that can measure glucose levels accurately and reliably have the capability to improve glycemic control and patient wellbeing. By integrating the sensing element, electronics, and a power source in a single package, noninvasive monitors are creating new options for caregivers and their diabetes patients. Signal processing improvements – include improved signal-to-noise ratios and interference filtering – will continue to be critical to the commercialization prospects of noninvasive monitors.

What You Will Learn

- What are the noninvasive monitoring technologies and devices that are moving toward commercialization and that are expected to have an impact on the diabetes management market by the end of the decade?
- What are the products currently under development, and what is their current status in terms of market readiness and product validation?
- What are the signification product development and commercialization issues facing the current generation of noninvasive glucose monitors?
- Who are the companies behind noninvasive glucose monitors, what are their capabilities and risk factors and what are their key supply chain issues?
- What are the commercialization prospects of the noninvasive glucose monitors?
- What are the significant market factors that will impact the market for noninvasive glucose monitors?



Table Of Contents

Noninvasive Glucose Monitors
Executive Summary

Diabetes Management Market Overview

Diabetes Economics
Monitoring Glucose Levels
Key Factors in Patient Compliance
Market Drivers
Industry Alignment and Competitive Landscape

New Generation Monitor Design Factors

Measuring Interstitial Fluid vs. Blood Glucose Levels
Reliability
Data Collection and Reporting
Measurement Frequency
Patient/User Interface
Emerging Technologies

Noninvasive Glucose Measurement Technologies

Detection Technology
Electro-Physiology
Impedence
Photoacoustic
Resistance
Spectroscopy
Thermal Emission/Thermography
Important Private Research Programs

Commercialization Factors

Calibration Frequency
Accuracy and Precision
Sensitivity
Sensor Technology and Signal Processing Advances

Market Factors

Regulations
Clinical Trials
Patient/Consumer Sentiment
Diabetes Demographics

Noninvasive Glucose Monitor Product Assessments

Spectroscopy
Raman
Occlusion Spectroscopy
Impedance Spectroscopy
Fluorescence
NIR
Electrical Resistance
Multimode Sensing
Ocular
Transdermal
Electro-Physiology

Company Profiles

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.